The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to The European Union Withdrawal Act 2018, as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.
25 September 2024
Chrysalis Investments Limited ("Chrysalis" or the "Company")
Debt Facility
Debt Facility
Subsequent to recent indications that it was considering options to enhance liquidity and so enable the Company's capital allocation policy ("CAP") to take effect at the earliest opportunity, including potential short-term gearing, the Company is pleased to announce that it has agreed a £70 million debt facility with Barclays Bank plc ("Barclays"). In addition to the committed £70 million, the facility also includes an uncommitted accordion of £15 million.
The Company will shortly inform Barclays of its intention to draw down the full £70 million commitment.
The agreement has a two-year tenor, which the Investment Adviser believes provides sufficient time for potential further realisations to occur, while falling within the three-year continuation period extension, which was approved by shareholders in March 2024. A market-rate margin plus the daily SONIA rate will be charged on borrowed amounts, with an arrangement fee also payable on the full commitment. The facility is repayable with no cost after one year.
The quantum of the facility is designed to cover the "buffer" element of the CAP (the "Buffer"), which the Board and Investment Adviser currently believe is appropriately set at approximately £50 million. The Buffer is designed to cover working capital and potential follow-on investments.
When the Buffer requirement is fulfilled by the facility, the Board will be in a position to consider the second pillar of the CAP, namely the return of up to £100 million to shareholders, likely through the commencement of share buybacks. The timing of any returns of capital will be dependent on receipt of funds from Barclays, amongst other relevant considerations, and a further announcement on this will be made in due course.
Given the above, both the Board and the Investment Adviser consider the benefits of the facility will outweigh the costs to the Company.
The maximum level of gearing in the Company, as measured against NAV and assuming the facility is fully drawn, is modest at approximately 8.1%, based on NAV as of 30 June 2024.
Liquidity
The Company's liquidity position as of 23 September 2024 was £47.2m, comprising cash of £45.3 million and a position in Wise worth £1.9 million. Once the £70 million drawdown on the facility is received, liquidity would increase to approximately £117.2 million, representing approximately 23% of its market capitalisation (as of 23 September 2024).
Nick Williamson and Richard Watts (Managing Partners of the Investment Adviser) comment:
"As we have articulated to shareholders in recent months, we believe the addition of a modest amount of debt will allow the Company to accelerate returns to shareholders as realisations occur within the portfolio. With the shares currently trading on a circa 41% discount to NAV and with a strong portfolio, we believe share buybacks could offer a compelling way to accrete NAV per share to the benefit of long-term shareholders.
We continue to work to maximise the valuations of the portfolio companies and to explore ways to realise this value."
-ENDS-
For further information, please contact
Media Montfort Communications: Charlotte McMullen / Imogen Saunders |
+44 (0) 7921 881 800 chrysalis@montfort.london |
|
|
Investment Adviser Chrysalis Investment Partners LLP: James Simpson
| +44 (0) 20 7871 5343 |
G10 Capital Limited (AIFM): | +44 (0) 20 7397 5450 |
Maria Baldwin |
|
|
|
Panmure Liberum: Chris Clarke / Darren Vickers
| +44 (0) 20 3100 2222 |
Deutsche Numis: Nathan Brown / Matt Goss
| +44 (0) 20 7260 1000 |
IQEQ Fund Services (Guernsey) Limited: Aimee Gontier / Elaine Smeja | +44 (0) 1481 231852 |
LEI: 213800F9SQ753JQHSW24
A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk
The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.
This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.
The Company is an alternative investment fund ("AIF") for the purposes of the AIFM Directive and as such is required to have an investment manager who is duly authorised to undertake the role of an alternative investment fund manager ("AIFM"). The AIFM appointed is G10 Capital Limited (part of the IQEQ Group).
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.